DEC 17, 2018 03:11 PM PST

Nanocapsules Improve The Delivery of Antiparasitic Drugs

WRITTEN BY: Nouran Amin

The efficacy of antiparasitic medications highly depends on how they dissolve and are absorbed by the body—limiting the therapeutic potential of traditionally insoluble anti-parasitic drugs.

The chemical structure of Triclabendazole used to treat flatworm infections.

Credit: PLOS

Now, an international team has sought ways to conquer this challenge by developing a new pharmaceutical formula using nanotechnology and nanomedicine approaches. The novel formula will specifically be used to administer the anti-parasitic drug—triclabendazole.

Triclabendazole is used to treat fascioliasis which is an infectious disease caused by flatworms. According to the World Health Organization, an estimated 2.4 million people are infected with fascioliasis. The disease is considered ‘neglected’ because it receives little to no attention and often goes undiagnosed.

Learn more about parasitic infections:

The new formula produces nanocapsules, less than a micron in size, to be loaded with triclabendazole and then bundled together for effective delivery. To bind the drug and coat the oil-core of capsules, researchers used a natural sugar polymer present in the exoskeleton of shellfish as well as the cell walls of some fungi. This polymer is called ‘chitosan’ and will specifically help stabilize the capsule and preserve the drug.

In the nanocapsule from, the drug would be 100 times more soluble than the current tablet form.

"Solubility is a critical challenge for effective anti-parasite medicine. We looked to tackle this problem at the particle level. Triclabendazole taken as a dose made up of billions of tiny capsules would mean the medicine would be more efficiently and quickly absorbed,” explains Professor Goycoolea, from the School of Food Science and Nutrition at the University of Leeds. "Through the use of nanocapsules and nanoemulsions, drug efficiency can be enhanced and new solutions can be considered for the best ways to target medicine delivery."

Source: PLOS ONE

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 15, 2019
Drug Discovery & Development
OCT 15, 2019
The Composition of Cerebrospinal Fluid in MS patients Could Be The Key To Treatments That Halt Progression
The range of disability for individuals living with multiple sclerosis (MS) varies significantly depending on the relapsing/remitting form of the disease....
OCT 15, 2019
Drug Discovery & Development
OCT 15, 2019
Leukemia Drug Effective for Treating Childhood Brain Cancer
Scientists at the University of California-San Diego have found that a chronic myeloid leukemia drug was found to treat medulloblastoma in mouse models mor...
OCT 15, 2019
Technology
OCT 15, 2019
Biomagents for Drug Discovery
Scientists have recently developed a chip-like device that utilizes tiny magnets that sort large populations of mixed cell types. "We casually agreed...
OCT 15, 2019
Drug Discovery & Development
OCT 15, 2019
Tailor-made Drug for Girl with Rare Genetic Disease
Researchers have used personalized medicine to develop a tailor-made genetic treatment for a girl diagnosed with a rare genetic disease known as Batten dis...
OCT 15, 2019
Health & Medicine
OCT 15, 2019
All you need to know about Orphan Drugs
Orphan drugs are medicinal products intended for the diagnosis, prevention, or treatment of very rare life-threatening diseases. To offset the high development cost of orphan drugs, in 1983,...
OCT 15, 2019
Microbiology
OCT 15, 2019
The Antimicrobial Power of Mucus is Revealed
We produce several liters of mucus every day to cover more than 200 square meters in the human body....
Loading Comments...